Background: Previous research on the association between serum albumin (ALB) and venous thromboembolism (VTE) has produced inconclusive results. The polygenic risk score is constructed from a set of independent risk variants associated with a disorder, enabling the identification of a larger fraction of the population at comparable or greater disease risk. It is still unknown whether ALB and genetic factors jointly contribute to the incidence of VTE. Objectives: The present study aimed to explore ALB, genetic susceptibility, and the risk of VTE. Methods: The present investigation was an analysis of prospectively collected data from UK Biobank, a population-based, longitudinal cohort. Cox proportional models were used to calculate hazard ratios and 95% CIs for VTE. The Kaplan-Meier curve was utilized to visualize the cumulative risk of VTE according to different serum ALB levels, and the restricted cubic spline model was leveraged to explore the exposure-response relationship among ALB levels and VTE risk. Results: During median follow-up of 13.5 years, 11,502 cases with VTE were diagnosed among 417,113 participants in the UK Biobank. The lower ALB levels were associated with a higher risk for VTE. Individuals with both a high genetic risk and lowest ALB level had the highest risk of VTE (hazard ratio, 3.89; 95% CI, 3.41-4.43), compared with those with low genetic risk and highest ALB level. The positive joint effects of low ALB and polygenic risk score increased the risk of VTE in individuals with high genetic risk. This study excluded non-European patients and primarily focused on the European population, which may limit the generalizability of the findings. Conclusion: Low serum ALB levels were linked to an increased risk of VTE, which was in accordance with a linear dose-response relationship. There was a positive additive effect of ALB and genetic susceptibility on the risk of VTE. ALB could serve as a biomarker for predicting the risk of VTE.
机构:
Harvard Med Sch, Div Cardiovasc Med, Beth Israel Deaconess Med Ctr, Dept Med, 930,Commonwealth Ave 3, Boston, MA 02215 USAHarvard Med Sch, Div Cardiovasc Med, Beth Israel Deaconess Med Ctr, Dept Med, 930,Commonwealth Ave 3, Boston, MA 02215 USA
Chi, Gerald
Gibson, C. Michael
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Med Sch, Div Cardiovasc Med, Beth Israel Deaconess Med Ctr, Dept Med, 930,Commonwealth Ave 3, Boston, MA 02215 USAHarvard Med Sch, Div Cardiovasc Med, Beth Israel Deaconess Med Ctr, Dept Med, 930,Commonwealth Ave 3, Boston, MA 02215 USA
Gibson, C. Michael
Liu, Yuyin
论文数: 0引用数: 0
h-index: 0
机构:
Baim Inst Clin Res, Boston, MA USAHarvard Med Sch, Div Cardiovasc Med, Beth Israel Deaconess Med Ctr, Dept Med, 930,Commonwealth Ave 3, Boston, MA 02215 USA
Liu, Yuyin
Hernandez, Adrian F.
论文数: 0引用数: 0
h-index: 0
机构:
Duke Univ, Durham, NC USA
Duke Clin Res Inst, Durham, NC USAHarvard Med Sch, Div Cardiovasc Med, Beth Israel Deaconess Med Ctr, Dept Med, 930,Commonwealth Ave 3, Boston, MA 02215 USA
Hernandez, Adrian F.
Hull, Russell D.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calgary, Fac Med, Div Cardiol, Calgary, AB, CanadaHarvard Med Sch, Div Cardiovasc Med, Beth Israel Deaconess Med Ctr, Dept Med, 930,Commonwealth Ave 3, Boston, MA 02215 USA
Hull, Russell D.
Cohen, Alexander T.
论文数: 0引用数: 0
h-index: 0
机构:
Kings Coll London, Dept Haematol Med, Guys Hosp, London, England
Kings Coll London, Dept Haematol Med, St Thomas Hosp, London, EnglandHarvard Med Sch, Div Cardiovasc Med, Beth Israel Deaconess Med Ctr, Dept Med, 930,Commonwealth Ave 3, Boston, MA 02215 USA
Cohen, Alexander T.
Harrington, Robert A.
论文数: 0引用数: 0
h-index: 0
机构:
Stanford Univ, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USAHarvard Med Sch, Div Cardiovasc Med, Beth Israel Deaconess Med Ctr, Dept Med, 930,Commonwealth Ave 3, Boston, MA 02215 USA
Harrington, Robert A.
Goldhaber, Samuel Z.
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA USAHarvard Med Sch, Div Cardiovasc Med, Beth Israel Deaconess Med Ctr, Dept Med, 930,Commonwealth Ave 3, Boston, MA 02215 USA